Insulet Corp (PODD) stock
PODDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 21/3046% below fair value
$150.03+1.97 (+1.33%)
Close on Nov 11, 2026Market cap $10.41BP/E 24.4Yield –
Insulet enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Insulet's enterprise value was $10.95B on Nov 11, 2026, against $23.94B a year earlier. Over the last 5 years it ranged from $9.58B to $25.16B, with a median of $17.87B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $10.95B | -47.4% |
| 2025 | Dec 31, 2025 | $20.83B | +10.7% |
| 2024 | Dec 31, 2024 | $18.81B | +18.4% |
| 2023 | Dec 29, 2023 | $15.89B | -24.7% |
| 2022 | Dec 30, 2022 | $21.11B | +12.6% |
| 2021 | Dec 31, 2021 | $18.75B | +11.2% |
| 2020 | Dec 31, 2020 | $16.86B | +53.9% |
| 2019 | Dec 31, 2019 | $10.96B | +113.1% |
| 2018 | Dec 31, 2018 | $5.14B | +20.9% |
| 2017 | Dec 29, 2017 | $4.26B | +86.9% |
| 2016 | Dec 30, 2016 | $2.28B | +4.4% |
| 2015 | Dec 31, 2015 | $2.18B | -16.2% |
| 2014 | Dec 31, 2014 | $2.60B | +31.4% |
| 2013 | Dec 31, 2013 | $1.98B | +84.5% |
| 2012 | Dec 31, 2012 | $1.07B | +36.1% |
| 2011 | Dec 30, 2011 | $788.47M | – |
See a number that looks wrong?